Using tumor biomarkers to tailor therapy in metastatic pancreatic cancer
(Mary Ann Liebert, Inc./Genetic Engineering News) A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | International Medicine & Public Health | Pancreas | Pancreatic Cancer | Study